Osgood-Schlatter disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:97335M93.2
Who is this for?
Show terms as
1Active trials30Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

Knee painHP:0030839Abnormal patella morphologyHP:0003045Limited knee extensionHP:0003066Irregular proximal tibial epiphysesHP:0006456Shuffling gaitHP:0002362Large kneeHP:0030866
Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Mar 2026Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes

Medical University of Gdansk — NA

TrialRECRUITING
Sep 2025Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes

Faculty of Medicine, Sousse — NA

TrialNOT YET RECRUITING
Jun 2025Schroth and Scapular Muscle Activation in Hyperkyphosis

Istanbul University - Cerrahpasa — NA

TrialRECRUITING
May 2025Osgood-Schlatter Disease in Athletic Children

Kafrelsheikh University — NA

TrialNOT YET RECRUITING
Oct 2020Personalized Spine Study Group (PSSG) Registry

University of Colorado, Denver

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Osgood-Schlatter disease.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes
N/A
Actively Recruiting
PI: Bartosz Wilczyński, PhD (Medical University of Gdansk) · Sites: Gdansk, Pomeranian · Age: 1017 yrs

Specialists

Showing 25 of 30View all specialists →
KK
Kasper Krommes
Specialist
PI on 1 active trial
GD
Gaston A Topol, Dr.
Specialist
PI on 1 active trial
BP
Bartosz Wilczyński, PhD
Specialist
PI on 1 active trial
JM
Jean-Francois LUCCIANI, MD
Specialist
PI on 1 active trial
MS
Marco Sapienza
ENGLEWOOD, NJ
Specialist
1 Osgood-Schlatter disease publication
SS
Sebastian Sitko
Specialist
1 Osgood-Schlatter disease publication
EB
Ernest Baiget
Specialist
1 Osgood-Schlatter disease publication
IL
Isaac López-Laval
Specialist
1 Osgood-Schlatter disease publication
CN
Cornelia Neuhaus
Specialist
1 Osgood-Schlatter disease publication
CA
Christian Appenzeller-Herzog
Specialist
1 Osgood-Schlatter disease publication
OF
Oliver Faude
Specialist
1 Osgood-Schlatter disease publication
LL
Ludovico Lucenti
Specialist
1 Osgood-Schlatter disease publication
AC
Alessia Caldaci
Specialist
1 Osgood-Schlatter disease publication
CC
Claudia de Cristo
Specialist
1 Osgood-Schlatter disease publication
GT
Gianluca Testa
Specialist
1 Osgood-Schlatter disease publication
OM
Oliver Faude, PD Dr. med.
Specialist
PI on 1 active trial
SM
Sergi Matas
Specialist
1 Osgood-Schlatter disease publication
FC
Francisco Corbi
Specialist
1 Osgood-Schlatter disease publication
JR
Joaquim Reverter-Masia
Specialist
1 Osgood-Schlatter disease publication
J&
Jesús Álvarez-Herms
Specialist
1 Osgood-Schlatter disease publication
AP
Ayşe Zengin Alpözgen, Assoc Prof.
Specialist
PI on 1 active trial
BM
Baron Lonner, MD
NEW YORK, NY
Specialist
PI on 1 active trial
JM
Jan Siewe, Dr. med.
Specialist
PI on 1 active trial
PM
Peter Newton, MD
OVERLAND PARK, KS
Specialist
PI on 2 active trials
RM
Rebecca L Carl, MD
CHICAGO, IL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Osgood-Schlatter disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Osgood-Schlatter diseaseForum →

No community posts yet. Be the first to share your experience with Osgood-Schlatter disease.

Start the conversation →

Latest news about Osgood-Schlatter disease

Disease timeline:

New recruiting trial: Schroth and Scapular Muscle Activation in Hyperkyphosis

A new clinical trial is recruiting patients for Osgood-Schlatter disease

New recruiting trial: Personalized Spine Study Group (PSSG) Registry

A new clinical trial is recruiting patients for Osgood-Schlatter disease

New recruiting trial: Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes

A new clinical trial is recruiting patients for Osgood-Schlatter disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Osgood-Schlatter disease

Are there clinical trials for Osgood-Schlatter disease?

Yes — 1 recruiting clinical trial is currently listed for Osgood-Schlatter disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Osgood-Schlatter disease?

25 specialists and care centers treating Osgood-Schlatter disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.